FDA-approved solutions are at the forefront of modern cosmetic procedures, offering safe and effective alternatives to traditional methods. One such solution rapidly gaining popularity is CoolSculpting, a revolutionary fat-freezing treatment that promises a slimmer, more sculpted figure without the need for invasive surgery. Utilising the innovative technology of Cryolipolysis, CoolSculpting freezes and eliminates fat cells […]
Datar Cancer Genetics, a world leading non-invasive cancer analytics and diagnostics company having its Research Head Quarters at Nasik, India, announced the publication of the internationally recognized MedTech Innovation Briefing (MIB) from the United Kingdom’s National Institute for Health and Care Excellence (NICE) on its CE marked ‘Trublood®- Prostate’ test to be used for precision […]
Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. TruBlood is a blood-based, non-invasive test for diagnostic evaluation of suspected cases of cancer who have been recommended a biopsy. The CE marking confirms that TruBlood meets […]
